G. Clerc

789 total citations
13 papers, 565 citations indexed

About

G. Clerc is a scholar working on Pharmacology, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, G. Clerc has authored 13 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Psychiatry and Mental health and 3 papers in Epidemiology. Recurrent topics in G. Clerc's work include Treatment of Major Depression (4 papers), Electroconvulsive Therapy Studies (2 papers) and Bipolar Disorder and Treatment (2 papers). G. Clerc is often cited by papers focused on Treatment of Major Depression (4 papers), Electroconvulsive Therapy Studies (2 papers) and Bipolar Disorder and Treatment (2 papers). G. Clerc collaborates with scholars based in France and Denmark. G. Clerc's co-authors include Meinhard Kieser, Y. Lecrubier, Ole Lemming, H. E. Høpfner Petersen, Thierry Bougerol, Michel Patris, R Poirier, P Balmès, R Parienté and B Dupont and has published in prestigious journals such as American Journal of Psychiatry, The Journal of Heart and Lung Transplantation and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

G. Clerc

12 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Clerc France 7 345 216 133 104 78 13 565
Richard Whale United Kingdom 12 130 0.4× 147 0.7× 74 0.6× 158 1.5× 44 0.6× 32 554
T. A. Ban United States 15 155 0.4× 276 1.3× 66 0.5× 128 1.2× 32 0.4× 73 709
Rachel Barron United Kingdom 4 463 1.3× 138 0.6× 34 0.3× 122 1.2× 49 0.6× 6 554
Aarti Gupta United States 7 270 0.8× 94 0.4× 24 0.2× 103 1.0× 25 0.3× 17 396
Halle Thurnauer United States 5 443 1.3× 98 0.5× 27 0.2× 229 2.2× 33 0.4× 5 533
E. Lehmann Germany 13 61 0.2× 137 0.6× 44 0.3× 18 0.2× 25 0.3× 40 451
Heather House United Kingdom 7 868 2.5× 50 0.2× 18 0.1× 269 2.6× 92 1.2× 9 1.1k
Melanie M. Ashton Australia 12 69 0.2× 231 1.1× 47 0.4× 25 0.2× 41 0.5× 32 573
E. O’Keefe Australia 6 181 0.5× 37 0.2× 32 0.2× 59 0.6× 31 0.4× 11 444
Márcio Alexandre Pena-Pereira Brazil 10 362 1.0× 58 0.3× 72 0.5× 146 1.4× 60 0.8× 14 646

Countries citing papers authored by G. Clerc

Since Specialization
Citations

This map shows the geographic impact of G. Clerc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Clerc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Clerc more than expected).

Fields of papers citing papers by G. Clerc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Clerc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Clerc. The network helps show where G. Clerc may publish in the future.

Co-authorship network of co-authors of G. Clerc

This figure shows the co-authorship network connecting the top 25 collaborators of G. Clerc. A scholar is included among the top collaborators of G. Clerc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Clerc. G. Clerc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Clerc, G., et al.. (2018). Granulome de Majocchi pubien : une entité clinique de localisation inhabituelle. Annales de Dermatologie et de Vénéréologie. 145(12). S287–S288. 1 indexed citations
2.
Aguilar, Patrícia Pereira, et al.. (2006). Modulation of Natural Killer (NK) Receptors on NK (CD3−/CD56+), T (CD3+/CD56−) and NKT-like (CD3+/CD56+) Cells after Heart Transplantation. The Journal of Heart and Lung Transplantation. 25(2). 200–205. 8 indexed citations
3.
Lecrubier, Y., et al.. (2002). Efficacy of St. John’s Wort Extract WS 5570 in Major Depression: A Double-Blind, Placebo-Controlled Trial. American Journal of Psychiatry. 159(8). 1361–1366. 132 indexed citations
4.
Clerc, G.. (2001). Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine. International Clinical Psychopharmacology. 16(3). 145–151. 54 indexed citations
5.
Patris, Michel, et al.. (1996). Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice. International Clinical Psychopharmacology. 11(2). 129–136. 75 indexed citations
6.
Clerc, G., et al.. (1994). A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. International Clinical Psychopharmacology. 9(3). 139–144. 235 indexed citations
7.
Balmès, P, et al.. (1991). Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections. European Journal of Clinical Microbiology & Infectious Diseases. 10(5). 437–439. 39 indexed citations
8.
Clerc, G.. (1991). Atherosclerosis as an immune disease?. Medical Hypotheses. 36(1). 24–26. 4 indexed citations
10.
Clerc, G. & Michel Clerc. (1986). Ecology and arteriosclerosis. Medical Hypotheses. 21(1). 97–103. 1 indexed citations
11.
Lempérière, T, et al.. (1984). [Haloperidol decanoate. Results of an open-ended multicentric study in chronic psychotic states].. PubMed. 10(5). 217–22.
12.
Clerc, G., et al.. (1977). [Study of 20 cases of apparently primary pulmonary arterial hypertension].. PubMed. 70(2). 191–9. 1 indexed citations
13.
Bertrand, E, et al.. (1976). [50 cases of acute malaria: symptomatic study, especially cardiac].. PubMed. 68(5). 456–66. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026